Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tally Levy

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Gynecologic Oncology|December 8, 2004
Phase II study of weekly topotecan in patients with recurrent or persistent epithelial ovarian cancerTally Levy, Moshe Inbar, Joseph Menczer, et al.
American Journal of Obstetrics and Gynecology|February 20, 2007
Distribution of cervical intraepithelial neoplasia across the cervix is randomSamuel Lurie, Miri Eliaz, Mona Boaz, et al.
The Journal of Obstetrics and Gynaecology Research|October 9, 2008
Group A Streptococcus causing a life-threatening postpartum necrotizing myometritis: a case reportSamuel Lurie, Hananya Vaknine, Alexander Izakson, et al.
Gynecologic Oncology|January 1, 2013
The significance of the pattern of serum CA125 level ascent to above the normal range in epithelial ovarian, primary peritoneal and tubal carcinoma patientsTally Levy, Roi Weiser, Mona Boaz, et al.
The Israel Medical Association Journal : IMAJ|January 7, 2015
CA125 expression in the tissue of uterine leiomyosarcomaJoseph Menczer, Letizia Schreiber, Esther Berger, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 8, 2012
Prognostic significance of rising serum CA-125 levels within the normal range in patients with epithelial ovarian, primary peritoneal, and tubal cancers, who, after initial treatment, had a complete clinical responseTally Levy, Roi Weiser, Mona Boaz, et al.
Acta Obstetricia Et Gynecologica Scandinavica|November 11, 2009
COX-2 expression in uterine carcinosarcomaJoseph Menczer, Letizia Schreiber, Oleg Sukmanov, et al.
Cancers|February 10, 2024
The Poor Prognosis of Acquired Secondary Platinum Resistance in Ovarian Cancer PatientsOsnat Elyashiv, Natalie Aleohin, Zohar Migdan, et al.
The Israel Medical Association Journal : IMAJ|November 6, 2017
Unexpected Significant Uterine Pathological Findings at Vaginal Hysterectomy Despite Unremarkable Preoperative WorkupYossi Mizrachi, Samer Tannus, Jacob Bar, et al.
Archives of Gynecology and Obstetrics|June 20, 2020
Characteristics and prognosis of borderline ovarian tumors in pre and postmenopausal patientsOri Tal, Hadas Ganer Herman, Ohad Gluck, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|December 8, 2004
Phase II study of weekly topotecan in patients with recurrent or persistent epithelial ovarian cancerTally Levy, Moshe Inbar, Joseph Menczer, et al.
American Journal of Obstetrics and Gynecology|February 20, 2007
Distribution of cervical intraepithelial neoplasia across the cervix is randomSamuel Lurie, Miri Eliaz, Mona Boaz, et al.
The Journal of Obstetrics and Gynaecology Research|October 9, 2008
Group A Streptococcus causing a life-threatening postpartum necrotizing myometritis: a case reportSamuel Lurie, Hananya Vaknine, Alexander Izakson, et al.
Gynecologic Oncology|January 1, 2013
The significance of the pattern of serum CA125 level ascent to above the normal range in epithelial ovarian, primary peritoneal and tubal carcinoma patientsTally Levy, Roi Weiser, Mona Boaz, et al.
The Israel Medical Association Journal : IMAJ|January 7, 2015
CA125 expression in the tissue of uterine leiomyosarcomaJoseph Menczer, Letizia Schreiber, Esther Berger, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 8, 2012
Prognostic significance of rising serum CA-125 levels within the normal range in patients with epithelial ovarian, primary peritoneal, and tubal cancers, who, after initial treatment, had a complete clinical responseTally Levy, Roi Weiser, Mona Boaz, et al.
Acta Obstetricia Et Gynecologica Scandinavica|November 11, 2009
COX-2 expression in uterine carcinosarcomaJoseph Menczer, Letizia Schreiber, Oleg Sukmanov, et al.
Cancers|February 10, 2024
The Poor Prognosis of Acquired Secondary Platinum Resistance in Ovarian Cancer PatientsOsnat Elyashiv, Natalie Aleohin, Zohar Migdan, et al.
The Israel Medical Association Journal : IMAJ|November 6, 2017
Unexpected Significant Uterine Pathological Findings at Vaginal Hysterectomy Despite Unremarkable Preoperative WorkupYossi Mizrachi, Samer Tannus, Jacob Bar, et al.
Archives of Gynecology and Obstetrics|June 20, 2020
Characteristics and prognosis of borderline ovarian tumors in pre and postmenopausal patientsOri Tal, Hadas Ganer Herman, Ohad Gluck, et al.
Pageof 7